138 related articles for article (PubMed ID: 12761257)
1. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease.
Muntner P; Coresh J; Powe NR; Klag MJ
J Am Soc Nephrol; 2003 Jun; 14(6):1568-77. PubMed ID: 12761257
[TBL] [Abstract][Full Text] [Related]
2. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.
Hsu CY; Vittinghoff E; Lin F; Shlipak MG
Ann Intern Med; 2004 Jul; 141(2):95-101. PubMed ID: 15262664
[TBL] [Abstract][Full Text] [Related]
3. Projecting ESRD Incidence and Prevalence in the United States through 2030.
McCullough KP; Morgenstern H; Saran R; Herman WH; Robinson BM
J Am Soc Nephrol; 2019 Jan; 30(1):127-135. PubMed ID: 30559143
[TBL] [Abstract][Full Text] [Related]
4. Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1097-100. PubMed ID: 16267496
[TBL] [Abstract][Full Text] [Related]
5. Is there an epidemic of HIV Infection in the US ESRD program?
Eggers PW; Kimmel PL
J Am Soc Nephrol; 2004 Sep; 15(9):2477-85. PubMed ID: 15339998
[TBL] [Abstract][Full Text] [Related]
6. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
[TBL] [Abstract][Full Text] [Related]
7. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger.
Iseki K; Wakugami K; Maehara A; Tozawa M; Muratani H; Fukiyama K
Am J Kidney Dis; 2001 Dec; 38(6):1235-9. PubMed ID: 11728955
[TBL] [Abstract][Full Text] [Related]
8. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
[TBL] [Abstract][Full Text] [Related]
9. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
[TBL] [Abstract][Full Text] [Related]
10. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.
Burrows NR; Li Y; Geiss LS
Diabetes Care; 2010 Jan; 33(1):73-7. PubMed ID: 20040673
[TBL] [Abstract][Full Text] [Related]
11. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
Ward MM
Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
[TBL] [Abstract][Full Text] [Related]
13. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors.
Muntner P; Coresh J; Klag MJ; Whelton PK; Perneger TV
Am J Kidney Dis; 2002 Aug; 40(2):323-30. PubMed ID: 12148105
[TBL] [Abstract][Full Text] [Related]
14. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
[TBL] [Abstract][Full Text] [Related]
15. Diabetes prevalence, incidence, and complications among Alaska Natives, 1987.
Schraer CD; Bulkow LR; Murphy NJ; Lanier AP
Diabetes Care; 1993 Jan; 16(1):257-9. PubMed ID: 8422787
[TBL] [Abstract][Full Text] [Related]
16. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.
Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME
Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483
[TBL] [Abstract][Full Text] [Related]
17. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.
McClellan W; Speckman R; McClure L; Howard V; Campbell RC; Cushman M; Audhya P; Howard G; Warnock DG
J Am Soc Nephrol; 2007 Apr; 18(4):1344-52. PubMed ID: 17344425
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
20. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
Friedlander MA; Hricik DE
Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
